Description and Objectives:

Webinar Description: 

Stereotactic body radiotherapy (SBRT) and immunotherapy offer tremendous promise in the treatment of Non-Small Cell Lung Cancer (NSCLC). Optimal means of combining these therapies is an active area of investigation. The webinar will provide some insight into this emerging and powerful approach to management of NSCLC. 

Educational Objectives: 

• To learn how to coordinate use of immunotherapy and SBRT in oligoprogressive/ oligoremnant non-small lung cancer.
• To better understand the toxicity associated with immunotherapy and SBRT in the management of patients with non-small cell lung cancer.
• Examine emerging work in the use of concurrent or sequential immunotherapy for metastatic lung cancer, with site-directed SBRT.